1. MicroRNAs and Long Non-coding RNAs as Key Targets
    Onur Obut et al, 2023, Oncology: Genomics, Precision Medicine and Therapeutic Targets CrossRef
  2. Cigarette Smoking Alters the Expression of Circulating microRNAs and Its Potential Diagnostic Value in Female Lung Cancer Patients
    Eric Gustavo Ramírez-Salazar et al, 2021, Biology CrossRef
  3. Innovative nanomaterials for cancer diagnosis, imaging, and therapy: Drug delivery applications
    Mehrab Pourmadadi et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
  4. Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma
    Dangze Sun et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  5. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study
    Zhaolei Cui et al, 2015, Tumor Biology CrossRef
  6. The High Diagnostic Accuracy of Combined Test of Thyroid Transcription Factor 1 and Napsin A to Distinguish between Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta-Analysis
    Li Li et al, 2014, PLoS ONE CrossRef
  7. Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer
    Ivan A. Zaporozhchenko et al, 2016, PLOS ONE CrossRef
  8. TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis
    L Larzabal et al, 2014, British Journal of Cancer CrossRef
  9. Diagnostic Significance of Circulating Multiple miRNAs in Breast Cancer: A Systematic Review and Meta-Analysis
    Shuduo Xie et al, 2016, Biomarkers in Medicine CrossRef
  10. Molecular binary classification of NSCLC: miR-375 is a potential biomarker to differentiate SQCC from ADCC in Indian NSCLC patients
    Sangeet Bhaumik et al, 2017, Applied Cancer Research CrossRef
  11. Methylation‐induced downregulation of TFPI‐2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non‐small‐cell lung carcinoma
    Junko Hamamoto et al, 2015, Cancer Science CrossRef
  12. Decision tree‑based classifiers for lung cancer diagnosis and subtyping using TCGA miRNA expression data
    Masih Sherafatian et al, 2019, Oncology Letters CrossRef
  13. Dietary regulation of miRNA in precision medicine of lung cancer
    Priya Mondal et al, 2022, Epigenetics in Precision Medicine CrossRef
  14. Ornithine aminotransferase promoted the proliferation and metastasis of non‐small cell lung cancer via upregulation of miR‐21
    Yanfeng Liu et al, 2019, Journal of Cellular Physiology CrossRef
  15. Tyrosylprotein sulfotransferase 1 expression is negatively correlated with c-Met and lymph node metastasis in human lung cancer
    ZHIBIN JIANG et al, 2015, Molecular Medicine Reports CrossRef
  16. DMFVAE: miRNA-disease associations prediction based on deep matrix factorization method with variational autoencoder
    Pijing Wei et al, 2024, Frontiers of Computer Science CrossRef
  17. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer
    Satoshi Yoda et al, 2014, Lung Cancer CrossRef
  18. Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
    Kentaro Inamura, 2017, Cancers CrossRef
  19. Identification of miR-124a as a novel diagnostic and prognostic biomarker in non-small cell lung cancer for chemotherapy
    Pei Luo et al, 2017, Molecular Medicine Reports CrossRef
  20. MicroRNAs: Key Regulators in Lung Cancer
    Younes El Founini et al, 2021, MicroRNA CrossRef
  21. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis
    Ting-qing Gan et al, 2017, Medical Science Monitor CrossRef
  22. Combined Elevation of microRNA-196a and microRNA-196b in Sera Predicts Unfavorable Prognosis in Patients with Osteosarcomas
    Chun Zhang et al, 2014, International Journal of Molecular Sciences CrossRef
  23. Regulation of UGT2A1 by miR-196a-5p and miR-196b-5p
    Aimee K. Sutliff et al, 2019, Journal of Pharmacology and Experimental Therapeutics CrossRef
  24. MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy
    Yongan Song et al, 2023, International Journal of Molecular Sciences CrossRef
  25. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma
    Xuelian Li et al, 2014, Journal of Translational Medicine CrossRef
  26. MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer
    Jing-Hua Li et al, 2017, Oncotarget CrossRef
  27. Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications
    Weihong Zhao et al, 2014, Scientific Reports CrossRef
  28. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling
    Chaojing Lu et al, 2016, Molecular Medicine Reports CrossRef
  29. Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways
    Cristiano P. Souza et al, 2020, Cancers CrossRef
  30. Insights into the Diverse Roles of miR-205 in Human Cancers
    Ayla Valinezhad Orang et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  31. MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact
    Meik Kunz et al, 2017, Tumor Biology CrossRef
  32. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs
    Veronika Petkova et al, 2022, Medicine CrossRef
  33. miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
    Carmen Elena Condrat et al, 2020, Cells CrossRef
  34. MicroRNA-205 Mediates Proteinase-Activated Receptor 2 (PAR2) -Promoted Cancer Cell Migration
    Xu Yang et al, 2017, Cancer Investigation CrossRef
  35. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
    Shengjie Tang et al, 2021, Cancer Letters CrossRef
  36. Physiological and Pathological Functions of Mammalian MicroRNAs
    X. Ma et al, 2018, Comprehensive Toxicology CrossRef
  37. Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
    Marta Lucchetta et al, 2019, BMC Cancer CrossRef
  38. MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy
    Katerina Popovska-Jankovic et al, 2016, BioMed Research International CrossRef
  39. Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc
    Raquel Conde-Muiño et al, 2017, Oncotarget CrossRef
  40. Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions
    Yan Wang et al, 2017, Medicine CrossRef
  41. Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy
    Surya Kant Tripathi et al, 2019, AGO-Driven Non-Coding RNAs CrossRef
  42. miRNA in Molecular Diagnostics
    Maja Matulić et al, 2022, Bioengineering CrossRef
  43. Cluster Analysis According to Immunohistochemistry is a Robust Tool for Non–Small Cell Lung Cancer and Reveals a Distinct, Immune Signature-defined Subgroup
    William Sterlacci et al, 2020, Applied Immunohistochemistry & Molecular Morphology CrossRef
  44. MiR-196b Promotes the Invasion and Migration of Lung Adenocarcinoma Cells by Targeting AQP4
    Xuhui Wu et al, 2021, Technology in Cancer Research & Treatment CrossRef
  45. MicroRNA as tools and therapeutics in lung cancer
    Jennifer F. Barger et al, 2015, Respiratory Medicine CrossRef
  46. miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6
    Hongli Li et al, 2018, Oncology Letters CrossRef
  47. microRNA-155 promotes the proliferation of prostate cancer cells by targeting annexin 7
    ZHI-KANG CAI et al, 2015, Molecular Medicine Reports CrossRef
  48. MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment
    Kentaro Inamura et al, 2016, Journal of Clinical Medicine CrossRef
  49. Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection
    Maria Sromek et al, 2017, Cellular Oncology CrossRef
  50. Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles
    Chuang Li et al, 2018, Cell & Bioscience CrossRef
  51. Identification of Factors for the Preoperative Prediction of Tumour Subtype and Prognosis in Patients with T1 Lung Adenocarcinoma
    Wang-Yu Zhu et al, 2016, Disease Markers CrossRef
  52. Comparisons of microRNA Patterns in Plasma before and after Tumor Removal Reveal New Biomarkers of Lung Squamous Cell Carcinoma
    Vasily N. Aushev et al, 2013, PLoS ONE CrossRef
  53. MiR-205 and MiR-375 MicroRNA Assays to Distinguish Squamous Cell Carcinoma from Adenocarcinoma in Lung Cancer Biopsies
    Santosh Patnaik et al, 2015, Journal of Thoracic Oncology CrossRef
  54. A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinoma
    Zahra Javanmardifard et al, 2024, Frontiers in Genetics CrossRef
  55. Relationship between diagnostic accuracy of microRNAs for NSCLC and number of combined microRNAs: an overview with meta-analysis
    Muyang Li et al, 2021, Expert Review of Molecular Diagnostics CrossRef
  56. Hsa-miR-375 is a predictor of local control in early stage breast cancer
    Franz Zehentmayr et al, 2016, Clinical Epigenetics CrossRef
  57. Homeobox A9 directly targeted by miR‐196b regulates aggressiveness through nuclear Factor‐kappa B activity in non‐small cell lung cancer cells
    Seong‐Lan Yu et al, 2016, Molecular Carcinogenesis CrossRef
  58. MicroRNA-profiles in lung adenocarcinomas
    Åslaug Helland, 2016, Expert Review of Precision Medicine and Drug Development CrossRef
  59. Clinical Epigenetics of Lung Cancer
    S.M. Langevin et al, 2017, Translating Epigenetics to the Clinic CrossRef
  60. A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma
    Hui Li et al, 2017, Oncotarget CrossRef